Stocks and Investing Stocks and Investing
Thu, November 3, 2022
[ 12:00 AM ] - WOPRAI
Buck Horne Maintained (WY) at Strong Buy with Decreased Target to $38 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
John Ivankoe Maintained (YUM) at Hold with Increased Target to $122 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Christopher Carril Maintained (YUM) at Hold with Increased Target to $128 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Maintained (YUM) at Hold with Increased Target to $122 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jon Tower Maintained (YUM) at Strong Buy with Increased Target to $149 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Connor Lynagh Maintained (XYL) at Buy with Increased Target to $105 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Connor Lynagh Maintained (XYL) at Hold with Increased Target to $95 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Joseph Spak Maintained (TEL) at Buy with Decreased Target to $138 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Samik Chatterjee Maintained (TEL) at Hold with Decreased Target to $135 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Christopher Glynn Maintained (TEL) at Buy with Decreased Target to $133 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jim Suva Maintained (TEL) at Hold with Decreased Target to $125 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Chris Snyder Maintained (TEL) at Strong Buy with Decreased Target to $150 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Brad Sills Downgraded (BILI) to Hold and Decreased Target to $12 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Thomas Singlehurst Maintained (BFAM) at Strong Buy with Decreased Target to $92 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Mark Delaney Maintained (BDC) at Hold with Increased Target to $76 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Lloyd Byrne Maintained (BE) at Strong Buy and Held Target at $29 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (BEN) at Hold with Decreased Target to $22 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Susan Maklari Maintained (BCC) at Hold with Increased Target to $72 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Adam Tindle Maintained (CDW) at Buy with Decreased Target to $200 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Erik Woodring Maintained (CDW) at Buy with Increased Target to $210 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jim Suva Maintained (CDW) at Strong Buy with Decreased Target to $210 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (CHE) at Buy with Increased Target to $545 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Bill Carcache Downgraded (CFR) to Hold on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Thomas Singlehurst Maintained (CHGG) at Hold with Increased Target to $29 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Silber Maintained (CHGG) at Hold with Increased Target to $26 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
David Saxon Maintained (STAA) at Strong Buy with Decreased Target to $83 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Ryan Zimmerman Maintained (STAA) at Strong Buy with Decreased Target to $80 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Gil Blum Maintained (SRPT) at Strong Buy with Decreased Target to $158 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Judah Frommer Maintained (SRPT) at Hold with Increased Target to $101 on, Nov 3rd, 2022
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (SRPT) at Buy with Decreased Target to $190 on, Nov 3rd, 2022

Brian Abrahams Maintained (SRPT) at Buy with Decreased Target to $190 on, Nov 3rd, 2022


Published on 2024-10-27 23:54:02 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $193 to $190 on, Nov 3rd, 2022.

Brian has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $141 on, Thursday, October 13th, 2022


This is the rating of the analyst that currently disagrees with Brian

  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $145 on, Monday, October 17th, 2022
Contributing Sources